CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2024 ,inter alia, to consider and approve Annual audited financial results of the Company for the year ended March 31, 2024 (both standalone & consolidated) and declaration of Interim Dividend, if any, for the FY 2023-24 and fixation of record date for determining the eligibility of shareholders.